BioDlink International Company Limited

As of December 31, 2024, BioDlink International Company Limited carries a market capitalization of 1.30B, placing it among publicly traded companies globally. Its enterprise value stands at 1.31B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

BioDlink International Company Limited's next confirmed earnings release is scheduled for March 25, 2027.

As of December 31, 2024, BioDlink International Company Limited has 725.20M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, BioDlink International Company Limited maintains a current ratio of 1.79, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 22, 2026, BioDlink International Company Limited's stock has gained approximately 71.54% over the past 52 weeks. The 50-day moving average sits at 3.77, while the 200-day moving average is 3.92.

As of December 31, 2024, BioDlink International Company Limited holds 405.74M in cash and equivalents against 420.86M in total debt, resulting in a net debt position of 13.58M. Total book value stands at 776.51M, with working capital of 348.97M providing operational flexibility.